The following data collectively indicate that CDC25A regulated by SRSF10 contributes to HCC progression, thus identifying the AS of CDC25A, such as exon skipping, as a potential therapeutic target in HCC. This evidence concerns the gene CDC25A and hepatocellular carcinoma.